| Schedule of significant segment expenses |
| Schedule of significant segment expenses |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Eight Months Ended
June 30, |
|
|
Years ended
October 31, |
|
| |
|
2026 |
|
|
2025 |
|
|
2024 |
|
| Revenue |
|
$ |
5,868,000 |
|
|
$ |
5,199,000 |
|
|
$ |
4,620,000 |
|
| Cost of revenues |
|
|
(1,128,000 |
) |
|
|
(931,000 |
) |
|
|
(844,000 |
) |
| Salaries & consulting fees |
|
|
(2,087,000 |
) |
|
|
(2,956,000 |
) |
|
|
(3,034,000 |
) |
| Professional fees |
|
|
(857,000 |
) |
|
|
(575,000 |
) |
|
|
(497,000 |
) |
| Stock-based compensation |
|
|
(5,157,000 |
) |
|
|
(4,693,000 |
) |
|
|
(3,853,000 |
) |
| Lab expenses |
|
|
(393,000 |
) |
|
|
(387,000 |
) |
|
|
(208,000 |
) |
| Research & development |
|
|
(65,000 |
) |
|
|
(100,000 |
) |
|
|
(164,000 |
) |
| Commissions |
|
|
(678,000 |
) |
|
|
(521,000 |
) |
|
|
(734,000 |
) |
| Marketing |
|
|
(560,000 |
) |
|
|
(139,000 |
) |
|
|
(249,000 |
) |
| Office expenses & other |
|
|
(368,000 |
) |
|
|
(283,000 |
) |
|
|
(356,000 |
) |
| Other income (expenses), net |
|
|
387,000 |
|
|
|
(135,000 |
) |
|
|
614,000 |
|
| Net loss |
|
$ |
(5,038,000 |
) |
|
$ |
(5,521,000 |
) |
|
$ |
(4,705,000 |
) |
|